tiprankstipranks
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market
Holding TRVI?
Track your performance easily

Trevi Therapeutics (TRVI) Financial Statements

347 Followers

Trevi Therapeutics Financial Overview

Trevi Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.441; its P/E ratio is -6.53; Trevi Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -13.27M$ -12.36M$ -10.91M$ -7.80M$ -7.71M
EBITDA$ -13.21M$ -11.83M$ -10.87M$ -7.76M$ -7.67M
Net Income Common Stockholders$ -13.24M$ -12.35M$ -10.90M$ -7.82M$ -7.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 65.49M$ 69.50M$ 72.82M$ 82.97M$ 88.87M
Total Assets$ 68.91M$ 73.81M$ 78.56M$ 89.40M$ 95.90M
Total Debt$ 1.11M$ 1.19M$ 1.27M$ 1.34M$ 1.41M
Net Debt$ -64.38M$ -68.30M$ -71.55M$ -81.63M$ -87.46M
Total Liabilities$ 9.94M$ 7.64M$ 6.22M$ 6.86M$ 6.29M
Stockholders Equity$ 58.97M$ 66.17M$ 72.33M$ 82.55M$ 89.61M
Cash Flow-
Free Cash Flow$ -9.56M$ -8.71M$ -10.47M$ -6.38M$ -7.30M
Operating Cash Flow$ -9.56M$ -8.68M$ -10.47M$ -6.36M$ -7.28M
Investing Cash Flow$ 7.67M$ 2.77M$ -8.09M$ 12.85M$ 17.98M
Financing Cash Flow$ 4.98M$ 5.07M$ -28.00K$ -54.00K$ 1.51M
Currency in USD

Trevi Therapeutics Earnings and Revenue History

Trevi Therapeutics Debt to Assets

Trevi Therapeutics Cash Flow

Trevi Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis